Cannabics Pharmaceuticals closes in on European patent

Bethesda-based Cannabics Pharmaceuticals Inc. was informed Tuesday by the European Patent Office that the examining division intends to grant the company a european patent for the company's  application titled "A System and Method for High Throughput Screening of Cancer Cells." This patent application relates to the company's Cannabics CDx companion diagnostic drug sensitivity test, whereby a patient's biopsy is ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *